1. 1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007;109:8-14.
2. 2. Gage JR, Schwartz MH, Koop SE, Novacheck TF (eds). The identification and treatment of gait problems in cerebral palsy. London, UK: Mac Keith Press; 2009.
3. Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study;van der Houwen;Gait Posture,2011
4. 4. Molenaers G, Desloovere K, Eyssen M, Decaf J, Jonkers I, De Cock P. Botulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur J Neurol 1999;6(Suppl 4):S51-7.
5. 5. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 1999;6:S23-35.